SCYNEXIS will receive an upfront payment of $90 million with future performance-based milestone payments and tiered royalties
The upcoming portfolio of respiratory products aims to provide effective solutions for a range of respiratory conditions
Getinge has a strong market share in India within several product segments
SVB Financial Group and its subsidiaries were involved in over $1.4 billion in total venture financing raised from 2010 to 2022 for drug development
Stedycon Sted super-resolution fluorescence microscope
Licences should enable potentially millions of people living in areas most impacted by HIV to access this innovative prevention medicine through low-cost generic manufacturers
India has a pivotal role in eliminating TB
Essex enriches and complements Emmes’ services
This initiative encapsulates the essence of OPPI’s commitment towards enabling a healthier India
Various healthcare companies are already implementing high-tech solutions into existing healthcare systems.
Subscribe To Our Newsletter & Stay Updated
